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Summary
Transport of chloride through the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)
channel is a key step in regulating fluid secretion in vertebrates[1,2]. Loss of CFTR function leads
to cystic fibrosis (CF)[1,3,4], a disease that affects the lungs, pancreas, liver, intestine and vas
deferens. Conversely, un-controlled activation of the channel leads to increased fluid secretion and
plays a major role in several diseases and conditions including cholera[5,6] and other secretory
diarrheas [7] as well as Polycystic Kidney Disease (PKD)[8–10]. Understanding how CFTR
activity is regulated in vivo has been limited by the lack of a genetic model. Here, we used a
forward genetic approach in zebrafish to uncover CFTR regulators. We report the identification,
isolation and characterization of a mutation in the zebrafish cse1l gene that leads to the sudden and
dramatic expansion of the gut tube. We show that this phenotype results from a rapid
accumulation of fluid due to the un-controlled activation of the CFTR channel. Analyses in
zebrafish embryos and mammalian cells indicate that Cse1l is a negative regulator of CFTR-
dependent fluid secretion. This work demonstrates the importance of fluid homeostasis in
development and establishes the zebrafish as a much needed model system to study CFTR
regulation in vivo.
Results and Discussion
Following a genetic screen designed to identify mutants with defects in gut, liver or pancreas
organogenesis[11], we identified a recessive mutation, s866 (22.4% penetrance, n=548),
which causes a striking gut phenotype. In s866 mutants, internal organs appear to develop
normally until 96–100 hours post fertilization (hpf) at which time the gut tube undergoes a
process of expansion that results in a dramatically enlarged fluid-filled tube (Fig. 1). We
named this mutant baobab (bao), after the African tree that accumulates water in its trunk.
Using confocal microscopy, we observed that baos866 mutants develop a very flat epithelium
(devoid of folds) lining the lumen of this enlarged intestinal tube (Fig. 1A–E). Occasionally,
delaminating cells were observed. However, baos866 mutants still exhibit gut peristalsis and
*m.bagnat@cellbio.duke.edu; didier.stainier@ucsf.edu.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures and four supplemental figures.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
NIH Public Access
Author Manuscript
Curr Biol. Author manuscript; available in PMC 2011 October 26.
Published in final edited form as:













the intestinal cells retain apical membrane polarity, cadherin localization, tight junctions,
and basal laminin deposition (not shown). Using transmission electron microscopy (TEM),
we observed a dramatic reduction in cell height and microvilli length in baos866 mutant
enterocytes (Fig. 1D–E). Nevertheless, baos866 mutant enterocytes retain expression and
localization of the absorptive cell marker 4e8[12] (Supp. Fig. 1A). Although all
delaminating cells in baos866 mutants appeared to undergo apoptosis, we did not observe a
significant increase in apoptosis in mutants compared to WT (Sup. Fig. 1B). baos866 mutants
also exhibit exocrine pancreas degeneration and liver growth arrest after 96 hpf (Sup. Fig.
1C). To define the events leading to gut lumen expansion in baos866 mutants, we first
imaged the process from 96 to 120 hpf in larvae expressing Histone2A:GFP[13] using
Selective Plane Illumination Microscopy (SPIM)[14]. This approach allowed us to visualize
the shape and size of the gut tube and follow cell divisions. In WT larvae, the gut showed
only a relatively small (46%) and steady increase in tube diameter between 96 and 120 hpf
(Fig. 1H). Gut tube growth in WT was mostly due to cell divisions, increased folding of the
epithelium and an increase in cell height associated with enterocyte polarization (see also
Fig. 1B–C) but not to changes in luminal volume. In contrast, lumen expansion in the
mutant was dramatic (511%) and rapid, taking place in approximately 200 minutes, and
without cell division (Fig. 1F–G).
Next, we investigated the causes of gut lumen expansion in baos866 mutants. At the tissue
level, this phenotype is reminiscent of what occurs in the gut of mice exposed to cholera
toxin[5], where the lumen is greatly enlarged by the CFTR-dependent accumulation of
fluid[9]. CFTR is a vertebrate-specific gene[1]. Zebrafish CFTR shows a 55% identity and
75% similarity to human CFTR and is highly expressed in the gut by 4 dpf (see below and
A.N. & M.B. unpublished). To test whether lumen expansion in baos866 mutants was CFTR-
dependent, we treated WT and mutant larvae with CFTR inhibitors from 72 to 120 hpf.
Various CFTR inhibitors (Glibenclamide, CFTR172 and T08) effectively reduced the
appearance of severely enlarged guts in baos866 mutants (84% reduction for 5 μM T08, a
CFTR172 analogue[10], n=1017 in total, 242 mutants)(Fig. 2A). In addition, treatment of
baos866 mutants with the CFTR inhibitor T08 significantly increased enterocyte height and
microvilli length to levels close to WT (Supp. Fig. 4). Although the CFTR inhibitors
blocked lumen expansion, they did not prevent cell delamination, suggesting that cell
delamination/apoptosis and lumen expansion are two separable phenotypes.
We next investigated the effects of CFTR activation. Soaking 120 hpf WT larvae in water
containing a specific CFTR activator[15] (15 μM CFTR-Act9) led to a robust and reversible
accumulation of fluid, resulting in a dramatic expansion of the gut lumen and the flattening
of enterocytes in half of the larvae (50.8%, n=360)(Fig. 2Bi; Supp. Fig. 2). This response
had very similar kinetics and appearance (i.e. reduction in cell height and microvilli length)
to those observed upon lumen expansion in baos866 mutants, but did not cause cell
delamination (Fig. 2Bii; Supp. Fig. 4). Altogether, our data indicate that the increase in
lumen size observed in baos866 mutants results from the un-controlled, CFTR-dependent
accumulation of fluid in the gut lumen. Because the baos866 mutation is recessive, it follows
that Bao is a negative regulator of CFTR-dependent fluid secretion.
Since CFTR is regulated at multiple levels, including transcriptional and post transcriptional
stages, it is possible that the increased CFTR activity observed in baos866 mutants is due to
increased expression and/or differences in subcellular localization of the channel. To
investigate these possibilities, we raised an antibody against zebrafish CFTR. In western
blots it recognized a protein of approximately 190 Kda (Supp. Fig. 3A). Importantly, the
signal was dramatically reduced in extracts prepared from larvae injected with an anti-sense
morpholino against CFTR compared to un-injected controls (Supp. Fig. 3A), indicating that
the antibody recognizes CFTR specifically. In transverse sections, the antibody stained the
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apical surface of gut epithelial cells (Sup. Fig. 3B). Western blot and immunohistological
analyses revealed that CFTR protein levels or localization were not significantly different in
baos866 mutants compared to WT (Fig. 2C). These data suggest that Bao regulates CFTR-
dependent fluid secretion by controlling CFTR activity and rule out transcriptional
regulation, changes in CFTR steady state levels or subcellular distribution. However, we
cannot exclude the possibility that differences in CFTR recycling[16], which would be very
difficult to discern in vivo, also contribute to the increase in CFTR activity observed in
baos866 mutants.
To gain molecular insight into the cellular processes controlled by the Bao protein, we
undertook a positional cloning project to isolate the corresponding gene. Using standard
genetic mapping techniques, we defined a critical genomic interval on chromosome 12
containing only two genes, chromosome segregation 1-like (cse1l) and protein tyrosine
phosphatase receptor gamma (ptprg)(Fig. 3A). Next, we isolated cDNAs from WT and
mutant larvae for both genes. Sequencing of these cDNAs revealed the absence of exon 16
in the middle of the cse1l transcript that leads to a predicted premature stop codon in the
next exon (Fig. 3B–C). No mutations were found in the ptprg cDNA. Genomic DNA
sequencing revealed a T to A mutation upstream of exon 16’s splice acceptor site (Fig. 3B).
We confirmed the aberrant splicing of exon 16 in the mutant by reverse transcriptase PCR
on pools of RNA made from baos866 mutants and WT siblings (Fig. 3C). Cse1l was depleted
in extracts prepared from baos866 mutants compared to WT siblings as judged by
immunoblots using antibodies against the N-terminus of human CSE1L (Fig. 3Di).
However, we could not unequivocally detect the predicted truncated form of the protein in
extracts made from baos866 mutants due to the presence of a cross-reacting protein of the
same size (asterisk in Fig. 3Di). To determine whether the mutant cDNA produces a
truncated protein, we transfected HEK293 cells and performed an immunoblot analysis. The
mutant cDNA produced a polypeptide of approximately 60 KDa, in agreement with the size
prediction inferred from cDNA sequencing (Fig. 3Dii).
Next, we knocked down the expression of Cse1l and Ptprg using anti-sense morpholinos.
Knock down of Cse1l (Fig. 3Ei) but not Ptprg (not shown) phenocopied baos866.
Immunoblot analysis confirmed that the phenotype of the cse1l morphants showed a good
correlation with the level of Cse1l depletion (Fig. 3Eii). To determine the pattern of cse1l
expression, we performed an in situ hybridization (ISH) analysis during WT development.
The cse1l transcript was present at the 2-cell stage (Fig. 3F), indicating that it is maternally
provided. Expression was broad early on but became restricted to the endoderm and parts of
the brain by 48 hpf. At 96 hpf cse1l was strongly expressed in the gut, liver and exocrine
pancreas and parts of the brain and retina (Fig. 3F). Expression was strongest in the gut after
96 hpf, coinciding with the onset of the gut expansion phenotype. Thus, the expression
pattern of cse1l shows a good correlation with the baos866 phenotype, affecting mostly gut,
liver and pancreas. To determine the subcellular localization of the Cse1l protein, we stained
sections of 120 hpf WT larvae. At 120 hpf, Cse1l was found enriched in the gut and liver
where we also found expression by ISH. The protein localized to the sub-apical and apical
region of gut enterocytes and was also found associated with lateral and basal membranes
(Fig. 3G). Altogether our data indicate that bao corresponds to cse1l.
Cse1l was originally isolated in a screen looking for regulators of chromosome segregation
(hence the name) in yeast[17]. This highly conserved (86% identity, 93% similarity between
zebrafish and humans) and essential gene[18] has been implicated in apoptosis[19], nuclear-
cytoplasmic transport[20], cell-cell adhesion[21] and chromatin regulation[22]. Therefore, it
seems very likely that the cell delamination/apoptosis phenotype in baos866 mutants is
linked to the nuclear and lateral membrane functions of Cse1l. However, the role of Cse1l in
regulating CFTR-dependent fluid secretion is clearly separable from other functions (Fig.
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2Aii). Moreover, zebrafish mutations in the nucleoporin gene elys trigger apoptosis in the
gut but not fluid accumulation[23,24]. Our data suggest a functional interaction between
Cse1l and CFTR. To test whether these two proteins also interact physically, we performed
co-immunoprecipitation experiments in HEK293 cells expressing human HA-tagged CFTR
(CFTR-HA)[25] and GFP-Cse1l or GFP-Cse1ls866 respectively. Notably, CFTR-HA co-
immunoprecipitated with GFP-Cse1l but showed a much weaker interaction with GFP-
Cse1ls866 (Fig. 4Ai). At the immunofluorescence level, a fraction of GFP-Cse1l co-localized
with CFTR-HA (Fig. 4Aii). We also co-immunoprecipitated endogenous CFTR and Cse1l
from human intestinal Caco-2 cells (not shown). Interestingly, a recent mass spectrometric
analysis of CFTR-associated proteins identified CSE1L among several other potential CFTR
partners in various human cell lines[26].
To investigate whether Cse1l regulates fluid secretion in mammalian cells, we employed a
clone of Madin-Darby Canine Kidney (MDCK) cells that expresses endogenous CFTR
(MDCK-C7)[27] and performed 3D cultures. When grown in MatrigelTM, these cells form
hollow cysts that exhibit forskolin-stimulated, CFTR-dependent fluid transport and lumen
expansion[9,28]. Forskolin addition increases intracellular cAMP levels and stimulates
protein kinase A which in turn activates the CFTR channel through phosphorylation[29]. To
test the effect of Cse1l over-expression and knockdown we made stable MDCKC7 lines
over-expressing GFP-tagged WT and mutant zebrafish Cse1l (GFP-Cse1l and GFP-
Cse1ls866 respectively) and examined the response to forskolin in 3D cultures. Cse1l is
highly conserved between zebrafish and mammals and the fish protein can functionally
substitute for the mammalian protein (see below). Interestingly, while addition of forskolin
(1 μM for 16 hrs) led to a robust (25% increase in diameter or close to 200% increase in
volume) and significant (p<0.00001, n=161) enlargement of control (vector only) or GFP-
Cse1ls866 expressing cysts, it did not affect the size of GFP-Cse1l expressing cysts (p=0.695,
n=131) (Fig. 4). It is important to note that while cysts made from cells transfected with
vector only or GFP-Cse1ls866 possessed mostly very thin (stretched) cells surrounding a
single large lumen (100 μm on average), GFP-Cse1l-expressing cysts were mostly multi-
layered and contained multiple small lumens (1–10 μm). Thus, the difference in luminal
volume was in fact much greater than the 200% increase derived from measurements of cyst
diameter. Next, we knocked down (more than 80%) endogenous Cse1l expression using
lentivirus-mediated expression of short hairpin interfering RNAs (sh-RNAs) (Fig. 4Ci). The
DNA sequence differences between zebrafish and dog Cse1l make the zebrafish construct
insensitive to the sh-RNAs. (Fig. 4Ci). Upon Cse1l knockdown we observed a robust (48%
increase in diameter or more than 300% increase in total cyst volume) and significant
(p<0.00001, n=200) expansion of the lumen that could be blocked by GFP-Cse1l expression
(p=0.643, n=149). Finally, we assayed CFTR activity in HEK293 cells expressing CFTR by
using a halide-sensitive YFP variant (YFP-H148Q)[30] and found that Cse1l over-
expression strongly inhibited CFTR activity (Supp. Fig. 4). Together, these experiments
suggest that Cse1l is a negative regulator of CFTR activity in mammalian cells.
Altogether, our results are consistent with a scenario in which binding of Cse1l to CFTR
results in the inhibition of the channel. Alternatively, Cse1l may be required for the function
of a CFTR inhibitor. While we cannot exclude an effect on the activity of other channels or
channel cross regulation, the physical interaction of Cse1l with CFTR suggests that Cse1l
regulates CFTR activity directly.
Studies of CFTR function have relied mostly on cell culture and genetic association studies
of populations of CF patients. While these studies have provided very valuable insights, an
in vivo correlate has not yet been established. This work establishes zebrafish as a forward
genetics model system to study CFTR biology and demonstrates that these studies are
translatable to mammalian models.
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• Regulation of CFTR activity is critical during zebrafish gut development
• Loss of Cse1l function leads to the un-controlled activation of the CFTR
channel
• Cse1l is a negative regulator of CFTR-dependent fluid secretion
• Forward genetics in zebrafish allows the isolation of CFTR regulators
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Figure 1. baos866 mutants undergo a dramatic and rapid expansion of the gut lumen between 96
and 120 hpf
A: Brightfield image of 120 hpf WT and baos866 mutant larvae. Arrows point to the edges of
the gut lumen. B–C: Confocal images of cross-sections of 120 hpf WT (B) and baos866
mutant (C). The arrow points to a delaminating cell. f-actin (red), DAPI (blue), sb:
swimbladder. Scale bars: 50 μm. D–E: Dramatic shortening of microvilli (arrows) in
baos866 mutant enterocytes seen by TEM at 120 hpf. Remnants of apoptotic cells (insert)
found in the lumen. GC: goblet cell. Scale bars: 10 μm. F–I: Rapid expansion of the gut
lumen in baos866 mutants expressing H2A:GFP. F: still images (lateral views) from a
baos866 mutant SPIM recording between (96–120 hpf) showing first and last frames. G–H:
Kymographs from baos866 mutant (G) and WT (H) gut. Lumen expansion in the mutant
occurred in ~200 min, no cell division was observed. I: Still images (lateral views) from the
baos866 mutant SPIM recording corresponding to the kymograph shown in (G).
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Figure 2. Lumen expansion in baos866 mutants results from increased CFTR-dependent fluid
secretion
A: Inhibition of CFTR blocks lumen expansion in baos866 mutants. Ai: Brightfield images
of WT and baos866 mutants incubated with DMSO (0.1 %) or the CFTR inhibitor T08 (5
μM) from 72 to 120 hpf. Arrows point to the edges of the gut lumen. Aii: Confocal images
of cross-sections of 144 hpf control and T08-treated baos866 mutants. Arrowheads point to
delaminating cells. f-actin (red), DAPI (blue). Scale bars: 50 μm. Aiii: Quantification of the
gut phenotype in control and T08-treated baos866 mutants. Larvae were placed in three
phenotypic categories (no phenotype, mild or severe phenotype) and then genotyped. B:
Activation of CFTR in WT phenocopies the gut lumen expansion defect of baos866 mutants.
Bi: Brighfield image of 144 hpf WT larvae treated with DMSO (0.15%) or CFTR-Act9 (15
μM). Arrows point to the edges of the gut lumen. Bii: Confocal images of cross-sections of
144 hpf control and CFTR-Act9-treated WT larvae. f-actin:red, DAPI:blue. Scale bars: 20
μm. C: CFTR expression and localization is not affected in baos866 mutants compared to
WT. Ci: Immunoblot of 120 hpf WT and baos866 mutants probed against CFTR and β-
tubulin. Cii: Confocal images of wholemounts of 120 hpf WT and baos866 mutants stained
for CFTR. The arrows point to the apical surface of the gut. Anterior to the right.
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Figure 3. Isolation of the bao gene
A: Positional cloning of bao. The number of recombinants (rec.) for each marker is shown.
B: sequencing of genomic DNA from +/+, −/− and +/− larvae revealed a T to A mutation
(arrow) upstream of exon 16’s splice acceptor site. C: RT-PCR on pools of RNA made from
WT and baos866 mutants demonstrates defective splicing of exon 16 in baos866 mutants
leading to a premature stop codon in exon 17. Di: Cse1l is depleted in baos866 mutants. The
asterisk marks the position of a cross-reacting protein band. Dii: The baos866 mutation
produces a truncated protein that can be detected in immunoblots of transfected HEK293
cells. Ei: Knockdown of Cse1l using an anti-sense morpholino targeting the translation start
site phenocopies the baos866 mutation (22% penetrance at 5 dpf, n=220). Eii: Immunoblot
of 5 dpf un-injected and Cse1l morphants demonstrating knockdown of this protein. F: ISH
analysis using an anti-sense probe directed against the 3’ of the cse1l mRNA. G:
Immunofluorescence on WT sections showing Cse1l in the sub-apical (arrowhead) and
basolateral (arrow) regions of intestinal cells at 120 hpf. Scale bars: 50μm.
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Figure 4. Cse1l negatively regulates fluid secretion in mammalian MDCK-C7 cells
Ai: zebrafish GFP-Cse1l but not GFP-Cse1ls866 co-immunoprecipitates with human CFTR-
CTHA. Aii: partial co-localization (arrows) of GFP-Cse1l and CFTR-CTHA in transfected
HEK293 cells. Scale bar=10μm; N, nucleus. B: Over-expression of zebrafish GFP-Cse1l
abrogates the stimulatory effect of forskolin on CFTR-dependent fluid secretion in 3D
cultures of mammalian MDCK-C7 cells. Bi: MDCK-C7 cells were grown on MatrigelTM
for 4 d and then forskolin (1 μM) was added for 16 hrs before the cysts were fixed and
imaged. Green:GFP, red:f-actin, blue:β-catenin. Scale bars: 50μm. Bii: quantification of Bi
(n=161 for GFP-Cse1ls866; n=131 for GFP-Cse1l). Error bars: s.e.m. C: Depletion of Cse1l
leads to increased fluid secretion in 3D cultures of MDCK-C7 cells. Ci: Immunoblot
showing knockdown of dog Cse1l in Sh4 but not in control Sh-scr infected cells. Cii:
Knockdown of dog Cse1l leads to lumen expansion in control but not in GFP-Cse1l-
expressing MDCK-C7 cells in 3D cultures (5 d in MatrigelTM) following forskolin
treatment. red: f-actin; green:β-catenin (upper panels), GFP (lower panels); blue:Topro.
Scale bars: 50 μm. Ciii: quantification of (Cii). n=200 for control; n=149 for GFP-Cse1l.
Error bars: s.e.m.
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